Published 2025-01-01
“…Snjezana Zeba,1 Maja Surbatovic,2 Ivo Udovicic,1 Ivan Stanojevic,3 Danilo Vojvodic,3 Goran Rondovic,1 Katarina Mladenovic,1 Tanja Abazovic,2 Almina Hasanovic,4 Aleksandra N Ilic,5 Dzihan Abazovic,6 Wasim Khan,7 Dragan Djordjevic1 1Clinic of Anesthesiology and Intensive Therapy, Military Medical Academy, Faculty of Medicine of the Military Medical Academy, University of Defense, Belgrade, Serbia; 2Clinic of Anesthesiology and Intensive Therapy, Military Medical Academy, Belgrade, Serbia; 3Institute for Medical Research, Military Medical Academy, Faculty of Medicine of the Military Medical Academy, University of Defense, Belgrade, Serbia; 4Nephrology Clinic, Military Medical Academy, Belgrade, Serbia; 5Faculty of Medicine, University of
Pristina, Kosovska Mitrovica, Serbia; 6Atlas Hospital, Belgrade, Serbia, Aba Medica Healthcare Centre, Ulcinj, Montenegro; 7Division of Trauma & Orthopaedic Surgery, University of Cambridge, Addenbrooke’s Hospital, Cambridge, CB2 2QQ, UKCorrespondence: Maja Surbatovic, Clinic of Anesthesiology and Intensive Therapy, Military Medical Academy, 17 Crnotravska Street, Belgrade, 11000, Serbia, Tel +381 11 2665 125, Email maja.surbatovic@gmail.comPurpose: The aim of the retrospective, single-center study was to assess the prognostic value of immune cell-based and albumin-based ratios regarding lethal outcome in critically ill COVID-19 patients.Patients and Methods: We analyzed 612 adult critically ill COVID-19 patients admitted to the intensive care unit (ICU) between April 2020 and November 2022. …”
Get full text
Article